Skip to content

Cash & Equivalents at other companies

AngioDynamics logo
AngioDynamicsANGO
$37.81M-15.5%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$488.08M+23.4%
Solventum logo
SolventumSOLV
$561M+5.1%
MiMedx Group logo
MiMedx GroupMDXG
$159.77M+50.1%
United Therapeutics logo
United TherapeuticsUTHR
$1.28B-32.6%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$288.1M+160%

Other financials

Income statement

See full
Revenue$75.3M+22.8%
Gross profit$57.6M+27.1%
Operating income-$1.5M+66.2%
Net income-$1.8M+40.7%
EPS (diluted)-$0.08+38.5%

Balance sheet

See full
Total debt$15.2M-62.7%
Total equity$217.9M+5.9%
Total assets$272.1M-2.9%

Cash flow

See full
Operating cash flow-$339.0K-181%
CapEx$821.0K+117%
Free cash flow-$1.2M-3,153%

Valuation

See full
Market cap$631.58M+172%
Enterprise value$571.76M+203%
P/E31.1×+16.8×
P/S1.8×+1.0×

Profitability

See full
Gross margin76.4%+1.8pp
Operating margin9.4%+2.4pp
Net margin5.9%+0.4pp
FCF margin11.4%-1.5pp

Returns & leverage

See full
Return on equity9.6%+1.5pp
Debt / equity0.1×-0.1×
Current ratio4.2×-0.3×

Where this comes from

Reported directly by Tactile Systems Technology in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Tactile Systems Technology’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tactile Systems Technology's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tactile Systems Technology's cash & equivalents?
Tactile Systems Technology (TCMD) reported cash & equivalents of $74.99M in Q1 2026.
How has Tactile Systems Technology's cash & equivalents changed year-over-year?
Tactile Systems Technology's cash & equivalents decreased by 10.3% year-over-year, from $83.62M to $74.99M.
What is the long-term trend for Tactile Systems Technology's cash & equivalents?
Over 5 years (2020 to 2025), Tactile Systems Technology's cash & equivalents has grown at a 11.8% compound annual growth rate (CAGR), from $47.86M to $83.45M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.